Financials Intervacc AB

Stocks

Market Closed - Nasdaq Stockholm Other stock markets 20:00:00 16/07/2026 +04			5-day change	1st Jan Change
1.212 ^SEK	-3.04%		-6.77%	+31.17%

05-22	Intervacc AB Completes Successful Evaluation of Us Strain of Strangles Pathogen Ahead of Clinical Trials	CI
05-15	Sweden's Intervacc Elects New Chair	MT

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	5.241	9.684	8.015	11.79	20.09	17.7	30.05	121
Change	-	84.77%	-17.23%	47.06%	70.42%	-11.88%	69.77%	302.66%
EBITDA ¹	-23.24	-43.56	-68.98	-58.75	-47.09	-63.45	-65.95	-36.5
Change	-	-87.41%	-58.37%	14.83%	19.84%	-34.74%	-3.94%	44.66%
EBIT ¹	-29.39	-64.41	-93.58	-77.28	-83.5	-82.35	-84.85	-55.4
Change	-	-119.14%	-45.28%	17.42%	-8.05%	1.38%	-3.04%	34.71%
Interest Paid	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-29.38	-64.16	-91.46	-75.52	-80.82	-80.8	-83.65	-66
Change	-	-118.4%	-42.57%	17.44%	-7.02%	0.02%	-3.53%	21.1%
Net income ¹	-29.38	-64.16	-102.9	-75.52	-80.82	-80.8	-83.65	-66
Change	-	-118.41%	-60.31%	26.58%	-7.02%	0.02%	-3.53%	21.1%
Announcement Date	18/02/22	17/02/23	16/02/24	13/02/25	17/02/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021 Q2	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1
Net sales ¹	4.119	2.18	-	2.612	2.016	-	2.531	4.127	4.574	-	5.378	3.123	3.374	5	4.7	4.7	6	7.5	7.5	9	11.7
Change	-	-47.07%	-	-	-22.82%	-	-	63.06%	10.83%	-	-	-41.93%	8.04%	48.19%	-6%	0%	27.66%	25%	0%	20%	30%
EBITDA ¹	-	-	-	-9.805	-8.612	-	-	-	-	-	-10.32	-13.95	-17.52	-13.6	-15.4	-16.3	-16.7	-16.6	-16.8	-16.7	-15.9
Change	-	-	-	-	12.17%	-	-	-	-	-	-	-35.1%	-25.6%	22.37%	-13.24%	-5.84%	-2.45%	0.6%	-1.2%	0.6%	4.79%
EBIT ¹	-6.145	-8.798	-	-15.74	-14.58	-	-	-	-	-	-14.98	-36.38	-22.23	-18.55	-19.95	-21.65	-21.4	-21.3	-21.5	-21.4	-20.6
Change	-	-43.17%	-	-	7.34%	-	-	-	-	-	-	-142.9%	38.9%	16.55%	-7.55%	-8.52%	1.15%	0.47%	-0.94%	0.47%	3.74%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-6.152	-	-	-15.77	-14.62	-	-22.22	-18.06	-13.17	-	-14.32	-35.57	-21.72	-18.4	-19.4	-22	-	-	-	-	-
Change	-	-	-	-	7.32%	-	-	18.74%	27.06%	-	-	-148.4%	38.92%	15.3%	-5.43%	-13.4%	-	-	-	-	-
Net income ¹	-6.152	-8.729	-10.73	-15.77	-14.62	-17.84	-22.22	-18.06	-13.17	-17.76	-14.32	-35.57	-21.72	-18.4	-19.4	-22	-	-	-	-	-
Change	-	-41.89%	-22.88%	-47.02%	7.32%	-22.09%	-24.54%	18.74%	27.06%	-34.82%	19.38%	-148.4%	38.92%	15.3%	-5.43%	-13.4%	-	-	-	-	-
Announcement Date	31/08/21	18/02/22	20/05/22	31/08/22	10/11/22	29/08/24	14/11/24	13/02/25	14/05/25	29/08/25	19/11/25	17/02/26	13/05/26	-	-	-	-	-	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	-115	-45.5	-88.2	-34.3	-161	-93	-63	-54
Change	-	60.43%	-93.85%	61.11%	-369.39%	42.2%	32.26%	14.29%
Announcement Date	18/02/22	17/02/23	16/02/24	13/02/25	17/02/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	22.44	5.251	0.056	-	1.132	1.5	1.5	2
Change	-	-76.6%	-98.93%	-	-	32.51%	0%	33.33%
Free Cash Flow (FCF) ¹	-47.9	-75.92	-47.94	-53.9	-66.92	-72	-75	-63
Change	-	-58.5%	36.85%	-12.43%	-24.15%	-7.59%	-4.17%	16%
Announcement Date	18/02/22	17/02/23	16/02/24	13/02/25	17/02/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-443.45%	-449.76%	-860.64%	-498.41%	-234.44%	-358.47%	-219.47%	-30.17%
EBIT Margin (%)	-560.83%	-665.15%	-1,167.55%	-655.61%	-415.7%	-465.25%	-282.36%	-45.79%
EBT Margin (%)	-560.48%	-662.48%	-1,141.16%	-640.66%	-402.32%	-456.5%	-278.37%	-54.55%
Net margin (%)	-560.48%	-662.52%	-1,283.24%	-640.66%	-402.32%	-456.5%	-278.37%	-54.55%
FCF margin (%)	-913.95%	-783.99%	-598.14%	-457.29%	-333.14%	-406.78%	-249.58%	-52.07%
FCF / Net Income (%)	163.06%	118.34%	46.61%	71.38%	82.8%	89.11%	89.66%	95.45%
Profitability
ROA	-	-	-	-	-	-	-	-
ROE	-9.1%	-22.98%	-	-	-28.82%	-33.3%	-48.7%	-39%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	428.11%	54.22%	0.7%	-	5.64%	8.47%	4.99%	1.65%
CAPEX / EBITDA (%)	-96.54%	-12.06%	-0.08%	-	-2.4%	-2.36%	-2.27%	-5.48%
CAPEX / FCF (%)	-46.84%	-6.92%	-0.12%	-	-1.69%	-2.08%	-2%	-3.17%
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	6.145	4.954	3.142	2.143	0.9245	0.57	0.59	-
Change	-	-19.38%	-36.59%	-31.78%	-56.87%	-38.34%	3.51%	-
EPS ¹	-0.59	-1.28	-1.69	-1	-0.27	-0.22	-0.22	-0.165
Change	-	-116.95%	-32.03%	40.83%	73%	18.52%	0%	25%
Nbr of stocks (in thousands)	50,160	50,491	75,736	75,736	340,813	340,813	340,813	340,813
Announcement Date	18/02/22	17/02/23	16/02/24	13/02/25	17/02/26	-	-	-